CompoAtlas

Glucolibre 3D

Food supplement declared in France, declaration No 2023-2-123

Glucolibre 3D is a food supplement declared in France. Status: retrait du marché annoncé pour le 21 August 2028. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
Nutriorigines
Status
Retrait du marché annoncé pour le 21 August 2028
Form
Comprimé
Daily dose
2 comprimés
Directions for use
Prendre 2 comprimés à croquer par jour
Not recommended for (according to the manufacturer)
Enfants (moins de 12 ans)
Objectives stated by the manufacturer (these are not authorised claims)
Détoxifiant / Draineur

Declaration 191797, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Foeniculum vulgare Mill.FruitPoudre (de plantes séchées ou broyées)30 mg

Other active ingredients

NamePer day
Vinaigre de cidrenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Chlorure de chromeChromepas de limite (données insuffisantes)25 µg

Additives

E420, E967, E470b

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Les compléments alimentaires doivent être utilisés dans le cadre d’un mode de vie sain et ne pas être utilisés comme substituts d’un régime alimentaire varie´ et équilibré. Ne pas dépasser la dose journalière recommandée. A conserver au frais, au sec et a` l'abri de la lumière. Tenir hors de la portée des jeunes enfants. Non destiné aux enfants de moins de 12 ans. Mentions recommandées : Demander conseil a` un médecin ou pharmacien pour les enfants, les femmes enceintes ou allaitantes. Une consommation excessive peut entrainer des effets laxatifs.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Enter to analyse, Shift+Enter for a new line